Gro-Vida’s new Partnership with Canopy Growth GmbH for German Medicinal Cannabis Market

Exciting news as Gro-Vida secures a significant agreement with Canopy Growth Germany GmbH, a subsidiary of global cannabis leader Canopy Growth Corporation.

"Part of our global strategy is ensuring a diverse and high-quality supply chain, and Gro-Vida is an important piece of this strategy. Sourcing EU-GMP flower from Portugal, alongside our EU-GMP Canadian-grown cannabis flower, allows us to offer a versatile and competitive product portfolio in the German market while advancing our asset light strategy for growth."

Tara Rozalowsky, Chief Growth Officer & President, International, Canopy Growth.

Under the terms of the agreement, Gro-Vida will supply EU-produced GMP-certified medicinal cannabis flower to Canopy Growth Germany, set for exclusive sale in Germany’s rapidly growing medicinal cannabis market starting in the first half of 2025.

"We are incredibly proud to be working with Canopy Growth Germany.

It is a remarkable honour to have a global leader recognise the exceptional quality of cannabis produced here in Portugal. This is not only a testament to our hard work but points to the promising future of Portuguese-grown cannabis on the world stage.”

Mallory Bodnar, Managing Director at Gro-Vida.

This collaboration underscores Gro-Vida's commitment to producing high-quality, European-grown cannabis while supporting Canopy Growth’s strategy for expanding its European supply chain.

Read the full press releasefrom the 20th of November 20, 2024 on EINPresswire.com.